
XARlabs
Mixed reality simulations for medical professionals, enhancing surgical rehearsals and patient consent with high precision 3D models.
Date | Investors | Amount | Round |
---|---|---|---|
* | $2.3m | Seed | |
Total Funding | 000k |
Related Content
XARlabs specializes in developing advanced mixed reality simulations and platforms specifically designed for medical professionals. The company's flagship product, simXAR, offers state-of-the-art mixed reality technology that enhances the precision and realism of 3D models, providing immersive learning experiences. XARlabs integrates procedural rehearsal and patient consent tools, offering a comprehensive approach to surgical preparation. The technology is adaptable to various learning styles, transforming both individual and collaborative sessions into dynamic and engaging experiences. XARlabs operates in the medical education market, serving healthcare professionals by providing flexible and accurate simulations across multiple surgical scenarios. The business model revolves around offering these high-precision experiences worldwide, aiming to revolutionize the surgical field by integrating mixed reality into a wide range of applications. This includes enhancing surgical procedures, training, and driving robotics integration, ultimately redefining precision and efficiency in healthcare. Keywords: mixed reality, medical professionals, surgical rehearsals, 3D models, immersive learning, procedural rehearsal, patient consent, surgical preparation, healthcare, robotics integration.